{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:59:05Z","timestamp":1792198745180,"version":"4.4.0"},"reference-count":0,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,4,8]]},"DOI":"10.7759\/cureus.1144","type":"journal-article","created":{"date-parts":[[2017,4,8]],"date-time":"2017-04-08T12:13:20Z","timestamp":1491653600000},"source":"Crossref","is-referenced-by-count":92,"title":["Cardiovascular Risk of Nonsteroidal Anti-Inflammatory Drugs: An Under-Recognized Public Health Issue"],"prefix":"10.7759","author":[{"given":"Zoltan","family":"Varga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed rafay ali","family":"Sabzwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Vargova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.cureus.com\/articles\/6604-cardiovascular-risk-of-nonsteroidal-anti-inflammatory-drugs-an-under-recognized-public-health-issue","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:17:55Z","timestamp":1707506275000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cureus.com\/articles\/6604-cardiovascular-risk-of-nonsteroidal-anti-inflammatory-drugs-an-under-recognized-public-health-issue"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,8]]},"references-count":0,"URL":"https:\/\/doi.org\/10.7759\/cureus.1144","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4,8]]}}}